Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box
-
Upload
louis-cady-md -
Category
Health & Medicine
-
view
1.114 -
download
3
description
Transcript of Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box
![Page 1: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/1.jpg)
Louis B. Cady, MD – CEO & Founder – Cady Louis B. Cady, MD – CEO & Founder – Cady Wellness Institute Wellness Institute Adjunct Assoc. Professor –
Indiana University School of Medicine Department of Psychiatry
Child, Adolescent, Adult & Forensic Psychiatry – Evansville, Indiana
SCRATCHING YOUR HEAD PSYCHIATRY II: How to Think INSIDE the Allopathic Box… [and Practice Precisely, Effectively, and to
Maximum Benefit]
(c) 2012 Louis B. Cady, M.D. - all rights reserved
![Page 2: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/2.jpg)
“Slumber not in the tents of your fathers. The world is advancing. Advance with it.”
- Giuseppe Mazzine
![Page 3: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/3.jpg)
Relevance for your practice• ALL PRESCRIBERS - don’t kill your patient
with a drug-drug interaction.
• ALL PARTICIPANTS - Know bad/stupid psychopharmacology when you see it.– Be able to DO SOMETHING about it.
• Don’t diagnose someone as having “drug problems” when they DON’T.
• Better “MOA” understanding
![Page 4: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/4.jpg)
A quick look back in history
The Interpretation of Dreams – 1885 - 1890
Ugo Cerletti 1935Prozac - 1987
![Page 5: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/5.jpg)
The Therapeutic Trifecta of Psychiatry:ShrinkingShocking
or Drugging
[Supposedly the only three things you could do to a patient’s
brain…]
![Page 6: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/6.jpg)
Dangers with Psychiatry/psychotropics
• Failure to diagnose– (E.g “head case” and then they die of a medical problem)
• Failure to adequately treat• Failure to prescribe accurately (Rx-rx interaction)• Giving people side effects• Using the wrong drug• Ignorance about best options because “I always did it that
way.” • Getting people addicted• Practicing beyond your ability and expertise• Violating black box warnings
![Page 7: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/7.jpg)
Depression & Anxiety & a malpractice suit in 1 Easy Lesson
DEPRESSIONSIG: E- CAPS!
• Sleep• Sadness • Interest loss• Guilt• *Energy• Concentration• Appetite• Psychomotor Sx• Suicidal thinking
Gen. ANXIETY D.O.•Somatic Sx (“energy”,etc.)•WORRY•Irritability•Concentration•Keyed up•Insomnia (“sleep”)•Restlessness
SWICKIR is Quicker:
Worry + 3 = GAD (Baughman)5of 9 with 1 of 2 x 2 weeks
*ACCURATE MEDICAL diagnosis “mood disorder due to a general medical condition” AND r/o bipolar disorder
BEWARE BEWARE – “too much” energy
![Page 8: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/8.jpg)
Lifetime Prevalence of Common Psychiatric Disorders
Kessler 1994; Kessler 1995; DSM-IV-TR™ 2000.*In menstruating women.
Lifetime prevalence (%)0 2 4 6 8 10 12 14
7.8%PTSD
5.1%Generalized anxiety d.o
3.5%Panic disorder
2.5%OCD
16 18
Alcohol dependence 14.1%
Major depressive disorder 17.1%
13.3%Social anxiety disorder
5%*PMDD
![Page 9: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/9.jpg)
Epidemiology of DepressionPrevalence of Major Depression
Regier et al., 1988; Blazer et al., 1994
0
5
10
15
20
EpidemiologicCatchment Area (ECA)
National ComorbiditySurvey (NCS)
Percentof Patients
point prevalence (30 day)
lifetime prevalence
![Page 10: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/10.jpg)
PHQ-9 Symptom Checklist
1. Over the last 2 weeks, how often have youbeen bothered by the following problems?
Notat all
0
Severaldays
1
More than half the days
2
Nearly every day
3
a. Little interest or pleasure in doing things
b. Feeling down, depressed, or hopeless
c. Trouble falling or staying asleep, or sleeping too much
d. Feeling tired or having little energy
e. Poor appetite or overeating
f. Feeling bad about yourself, or that you are a failure…
g. Trouble concentrating on things, such as reading…
h. Moving or speaking so slowly…
i. Thoughts that you would be better off dead… Subtotals: 3 4 9
TOTAL: 16
Kroenke 2001.
![Page 11: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/11.jpg)
Depression—Impact on the Healthcare System
• Compared with those without depression, depressed individuals: – Utilize all types of healthcare services more
often
– Incur 1½ to 2 times greater healthcare costs
– increased length of hospital stay
– significant worsening of physical, social, and role functioning
Simon 1995; Luber 2000; Verbosky 1993; Wells 1989.
![Page 12: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/12.jpg)
% Patients Disabled 3+ Days
33.7%
19.45%
16.9%
3.1%
Comorbidity of Depression and Anxiety
Disability
Wittchen, Depress Anxiety, 2002
Percent of Patients With ≥1 Disability Day in Past Month
GAD + MDD
MDD/no GAD
GAD/no MDD
no GAD/no MDD
![Page 13: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/13.jpg)
Where does ADHD come from?
![Page 14: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/14.jpg)
Kids and Adults – Differences in HYPERACTIVE domain
AS A CHILD:• Squirming, fidgeting• Cannot stay seated• Cannot wait turn • Runs/climbs excessively• Cannot play quietly• On the go/driven by motor• Talks excessively• Blurts out answers• Intrudes, interrupts others
AS AN ADULT:• Work inefficiencies• Can’t sit through meetings• Cannot wait in line• Drives too fast• Self-selects very active job• Cannot tolerate frustration• Talks excessively• Makes inappropriate
comments• Interrupts others
Sources: DSM-IV (TR). APA 2000:85-93)Weiss MD, Weiss JR. J Clin Psychiatry 2004;65(Suppl 3):27-37.
![Page 15: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/15.jpg)
Horrigan J, et al. Presented at 47th Annual AACAP Meeting: October 24-29, 2000. New York, NY.
![Page 16: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/16.jpg)
Persistence of ADHD Into Adulthood• ADHD is a heterogeneous disorder associated with
considerable disability and comorbidity that, in many cases, persists into adulthood1
– Some studies have found persistence as high as 36.3%2
• Mood, anxiety, and substance use disorders are the most common comorbid disorders in adults with ADHD3
• Current prevalence of ADHD persistent into adulthood 4.4%4 (5% by new study – Willcut – Neurotherapeutics 2012
• Much of the treatment of adult ADHD can be based on experience in treating children/adolescents5
1. Barkley et al. J Abnorm Psychol. 2002;111:279-289.2. Kessler RC et al. Biol Psychiatry 2005 June;57(11):1442-51. [retrospective review of 3,197 14-44 yo
respondents in NCS-R]3. Biederman et al. Am J Psychiatry. 1993;150:1792-1798. 4. Kessler et al. Am J Psychiatry. 2006;163(4):716-
23. 5. Dodson WW. J Clin Psychol. 2005;61:589-606.
![Page 17: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/17.jpg)
Diagnostic Pearls - Cady• How’s work?
– How has your employment history been?
• How’s your mood? Your marriage (relationship)?• How was school for you?• Are people nervous driving with you?• Are there periods of time when you have too much
energy for no particular reason?• Do you ever have to have a beer at the end of the day to
relax?– [gently lead in to other substances, especially stimulants that
may have a CALMING effect]– “Have you ever taken any of your child’s ADD Rx?” [or other
stimulants, energy drinks, diet pills, or cocaine]
![Page 18: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/18.jpg)
Pharmacology Failures…
1. “Begin with the end in mind.” (Covey)
2. Start LOW – (rule of thumb – ½ what the drug rep and package insert says!)
3. Go up to the maximum tolerated dosage, with finesse.
– Tell them about “Goldilocks”
4. If it doesn’t work, add something complimentary (that makes sense).
![Page 19: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/19.jpg)
THE FACTS• SSRI’s treat depression AND/OR anxiety• Patients may INITIALLY need something else for daytime
anxiety or sleep.• BZD’s of choice:
– clonazepam 1 mg tablets – ½ to 1 twice daily to three times daily
– Diazepam – 5 mg =- ½ - 1 ½ twice daily to three times daily
• (first pass and second pass effects)• ANTIANXIETY RX (non BZD) – Buspirone, per package
insert. Push to 20 mg THREE TIMES DAILY or to the point of maximum tolerability for 4 – 6 weeks AT THAT DOSE. – Start with 5 mg. Can use WITH SSRI’s
![Page 20: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/20.jpg)
AVOID Alprazolam (Xanax ®)
• Addicting (and rapidly so)
• Can have seizures if rapidly withdrawn (structurally similar to carbamazepine)
• MD’s shot over it.
• NOT an “anti-anxiety” medication
• NOT a sleeper.
• Even if they need a BZD for anxiety, it doesn’t have to be Xanax.
![Page 21: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/21.jpg)
Sleepers – my preferences• Rozerem (brand) (a melatonin analog) – 8 (up to 16* mg) at
bedtime. VASTLY under-rated. May need to take 2 weeks before adequate effect. (* off-label dose)– Dual acting agent – homeostatic and circadian effects. 70x as
potent as melatonin. – Melatonin SR may also be a good agent.
• Trazodone (50 – 150mg ½ - 2 hrs before HS. (Note, off label “unapproved.” Warn on priapism).
• Lunesta (brand) – 2 – 3 mg. Try samples. Have mouthwash on hand. (Probably most predictable agent)
• Ambien 12.5 mg CR (brand) – legitimately lasts longer than zolpidem. Probably not as effective as Lunesta.
• Zolpidem – generic. People get hooked on it.• Paradigm: SYMPTOMATIC treatment – after depression is stabilized, fade
out the sleeper
![Page 22: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/22.jpg)
Why treatment failures occur: too much or too little…The REAL mechanism of action of SSRI’s
Animation © NEI, Inc. (Neuroscience Institute) and is used specifically with permission from Stephen Stahl, MD, Ph.D.
![Page 23: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/23.jpg)
Drug, drug... who's got the
drug?
![Page 24: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/24.jpg)
Depression/anxiety Rx:
• TCA
• Venlafaxine (Effexor)
• Duloxetine (Cymbalta)
• Mirtazapine (alpha 2)
• Desmethylvenlafaxine (Pristiq)
& others….
![Page 25: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/25.jpg)
Side Effects & Drug Interactions: The Doc Cady “Can’t s” of the TCA’s
PeePoop
SpitSpurtFocusThink
Stand up Stay awake
Stay thin
ANTICHOLINERGIC/ ANTIMUSCARINIC EFFECTS
Alpha-adrenergic blockade
"Antihistamine" effects
![Page 26: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/26.jpg)
“Drug-drug interactions” clinically relevant?!
![Page 27: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/27.jpg)
Drug-drug interactions: chum for legal “sharks”
![Page 28: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/28.jpg)
“Strattera [coupled with Prozac or Paxil] has been great for our admissions.”
-Dr. William Beute, MD
Pine Rest Campus Clinic
Grand Rapids, MI
April 21, 2004
[quoted with permission]
![Page 29: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/29.jpg)
Cytochrome p-450 2D6 inhibition measured as % increase in “Desipramine AUC” – in vivo data
Preskhorn, Alderman, et al. Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. J. Clin Psychopharmacol 1994;14:90-98;
Escitalopram package insert - note – different source of data, but same method
Critically important when combining with other Rx metabolized through 2D6
pathways
![Page 30: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/30.jpg)
SomeSome drugs metabolized through drugs metabolized through cytochrome P-450 IID6 systemcytochrome P-450 IID6 system
ADHDADHDAmphetaminesAmphetaminesSTRATTERASTRATTERA
AnalgesicsAnalgesics•AcetaminophenAcetaminophen•AspirinAspirin
AntacidsAntacids
AntiarrthymicsAntiarrthymics•Procainamide, Procainamide, •QuinidineQuinidine•EncainideEncainide•FlecainideFlecainide
AnticonvulsantAnticonvulsant•carbamazepinecarbamazepine
ANTI-PAINANTI-PAINCODEINE!CODEINE!
BronchodilatorsBronchodilators•TheophyllineTheophylline
CardiacCardiac•Digoxin; digitalisDigoxin; digitalis
CoughCough•DextromethorphanDextromethorphan
DiureticsDiuretics•ChlorthalidoneChlorthalidone•FurosemideFurosemide•HCTZHCTZ•TriamterineTriamterine
AntibioticsAntibiotics•TMP & SMXTMP & SMX•AmpicillinAmpicillin•ErythromycinErythromycin•PenicillinPenicillin•TetracyclineTetracycline
AntidepressantsAntidepressants•TCATCA’’s & s & ““2P2P’’ss””
AntihistaminesAntihistaminesAntihypertensivesAntihypertensivesAntipsychoticsAntipsychotics•ClozarilClozaril•RisperdalRisperdal•ZyprexaZyprexa
![Page 31: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/31.jpg)
The “not so selective” SSRI’s; how to “Do yourself a favor.”
drug SSRI? 2nd order effects Side effects possible
Escitalopram (Lexapro) now generic
Yes NOTHING (excess serotonin side effects only)
Sertraline (Zoloft) Yes Dopamine (1/3 as potent as amphetamine)
Agitation, nervousness; improved [ ]
Citalopram (Celexa)
Yes AntiH1 Sedation (note- FDA lowered max dose to 40mg)
Paroxetine (Paxil) Yes Ach NOT “NRI”
Doped up, TCA effects, neurocognitive problems, withdrawal. Sexual, Prostate sxs
Fluoxetine (Prozac)
Yes 5HT2C Agitation, appetite suppression
![Page 32: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/32.jpg)
New Agents, New Mechanisms(agent) (MOA) Differentiating points
Venlafaxine (“IR” and XR) (Effexor)
SSRI, NRI Nausea, GI side effects, sxl dysfunction
Duloxetine (Cymbalta) SSRI, NRI Same. Better tolerated. For pain w/ dep.
Desvenlafaxine (Pristiq) – “son of Effexor”
SSRI, NRI Better tolerated
Trazodone XR with Contramid® (OLEPTRO)
5HT2a/c BLOCKER, mild SSRI
Legitimate effect on depression/anxiety without doping up.
Vilazodone (Viibryd) SPA, SSRI ONLY SPARI. Weaker “SSRI.” Targets 5HT1A. Less sexual side effects.
Bupropion (“XL” – not “SR”) (Wellbutrin)
“NDRI” Possibility of anxiety & “wound up.” Improved concentration. Push to 450 mg. SZ warning..
![Page 33: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/33.jpg)
Duloxetine (Cymbalta) Versus Escitalopram (Lexapro) and Placebo: An 8-month, Double-Blind Trial in Patients With Major Depressive
DisorderPigott et al., Curr Med Res Opin, 2007
An illustrative study on picking your antidepressant…
![Page 34: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/34.jpg)
Total Score
*
Anxiety/Somatization Sleep Maier Retardation
SubscalesHAMD17 (MMRM)
*p<0.05
Comparison of Escitalopram and Duloxetine: 8-Month Trial
Pigott et al., Curr Med Res Opin, 2007
![Page 35: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/35.jpg)
Significantly Different Adverse Events (p<0.05 Duloxetine vs Escitalopram)
Comparison of Escitalopram and Duloxetine: 8-Month Trial
Percent of Patients
Pigott et al., Curr Med Res Opin, 2007
![Page 36: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/36.jpg)
• Remission rates for both escitalopram and duloxetine continued to improve over time
• Significantly more escitalopram-treated patients continued treatment compared to duloxetine-treated patients
• Escitalopram showed significant improvement vs duloxetine on the HAMD17 sleep subscale
• Compared to escitalopram, duloxetine significantly increased pulse and systolic blood pressure
Conclusions: they both worked the same; side effects were worse with duloxetine
Comparison of Escitalopram and Duloxetine: 8-Month Trial
Pigott et al., Curr Med Res Opin, 2007
![Page 37: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/37.jpg)
Two New Agents You Need to Know• Extended release Trazodone
– NOT “son of Trazodone”– Possibility of legitimate antidepressant effect with anti-anxiety
effect WITHOUT doping patient up.– A “SARI” – serotonin antagonist reuptake inhibitor
• Vilazodone – the only SPARI available. • How to appreciate:
– 5HT1A is receptor for antidepressant effect of serotonin– 5HT2A and 5HT2 C: anxiety, sleep disruption, sexual side
effects.– ANYTHING which works preferentially on 5HT1A is GOOD!
![Page 38: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/38.jpg)
XR Trazodone steady state dosing study
• (Levels done after 7 days steady state)
• 300 mg XR Traz AUC comparable to 100 mg IR Traz tid
• Cmax 42% lower than IR Trazodone– Translation – it
doesn’t dope the patient up.
Kramer, WG et al. Once-daily Trazodone: Overview of Pharmacokinetic Properties. Poster – ACCP 38th Annual Meeting, San Antonio, TX 2005
![Page 39: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/39.jpg)
XR Trazodone Food Effect Study
• PI says “take at night”
• CMax increase by 86% (!!!) under fed conditions. Peak is at 7 hours post dose (with feeding).
• Note – this may lead the enlightened prescriber to vary the time of dosing.
Kramer, WG et al. Once-daily Trazodone: Overview of Pharmacokinetic Properties. Poster – ACCP 38th Annual Meeting, San Antonio, TX 2005
![Page 40: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/40.jpg)
Vilazodone – a SPARI (per Stephen Stahl, MD, Ph.D.) – Serotonin Partial Agonist Reuptake Inhibitor
• Highly serotonergic. START LOW (5 mg).• Because of 5HT1A agonism, LESS “SSRI” effect is required.
![Page 41: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/41.jpg)
ADHD Rx for frontline medicine• Desiderata – get control, and keep it consistent for predictable
period of time
• Rules of thumb: don’t be guided on SIZE. START LOW. “Know the Biederman max” for MPH and amphetamine.
• Recommendations (for children and adult):– Focalin XR (Dexmethylphenidate XR) 5,10,15,20,30 and 40 mg capsules)
• Rationale: MPH based. FAST. 8 – 10 hours. Can dose twice daily (off-label), a.m. >pm. (can also start with ½ capsule)
– Vyvanse – (lisdexamfetamine [sic]) – 20,30,40,50,60,70 mg [= 7.5 – 30 mg] amphetamine equivalents. Lasts 12 – 14 hours. (Can dissolve in water – per PI!).
– Kapvay/Intuniv – FDA approved in kids. • Kapvay easier to use, better tolerated.
• Intuniv more potent, but more side effects (sedation)
![Page 42: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/42.jpg)
Practicing beyond your ability (and knowledge) – the second generation antipsychotics
• Definitions:– Mood stabilizer – something that stabilizes mood
(Lithium, carbamazepine, VPA)– Antipsychotic – something you give someone who is
PSYCHOTIC to get them UNPSYCHOTIC.– Antidepressant – something for depression.– “2nd generation antipsychotic (“SGA’s”) = S2/D2
blockers.”• Can “stabilize mood” as well as function as antipsychotics• Now some FDA approved for either add-on use or single agents
for “bipolar depression” (e.g., quietapine XR)
![Page 43: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/43.jpg)
Know who you’re playing with• SGA’s and WEIGHT GAIN (Cady experience)
– olanzapine/risperidone > quietapine> aripiprazole/arsenapine> lurasidone/ziprasidone
• (Zyprexa/Risperdal>Seroquel> Abilify/Saphris> Latuda/Geodon)
• EXPENSIVE: $400 – $600 /per month
• All will work for mania. NONE are pure “mood stabilizers.” Some make you fat.
• Some will work for depression but dope you up.
• Much less risky than 1st generation for tardive dyskinesia.
• Axiom: refine your psychopharmacology before going to look for an SGA.
• If you have to use one (for bipolar or psychosis, Lurasidone is probably most benign – 40 – 80 mg twice daily (or 160 mg HS)
![Page 44: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/44.jpg)
Cady recommendation for SGA’s in primary care
• As little as possible.
• Do NOT use as primary mood stabilizers for bipolar disorder. Use lithium (Type I) VPA (Type I/II) or Lamotrigine – which is a real option. Check levels and labs as needed
• Can use if single, or better yet, DOUBLE mood stabilizers don’t work.
• Abilify (only “dopaminergic” SGA) probably best for antidepressant augmentation at LOW DOSE.
– 2 – 4 or 5 mg is optimum dose for this. (Start with ½ of a 2 mg and go up)
– Onset is FAST when it happens.
• Olanzapine is most dependable for rapid onset and control of manic episode, or agitation, or EXTREME PANIC & anxiety (off label).. Lurasidone may be best tolerated.
![Page 45: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/45.jpg)
A quick look back in psychiatric tx:
The Interpretation of Dreams – 1885 - 1890
Ugo Cerletti 1935Prozac - 1987
![Page 46: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/46.jpg)
The Therapeutic Trifecta of Psychiatry:ShrinkingShocking
or Drugging
[Supposedly] the only three things you could do to a patient’s
brain…]
![Page 47: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/47.jpg)
STAR*D Study demonstrates that current treatment has limited effectiveness
Trivedi (2006) Am J Psychiatry; Rush (2006) Am J Psychiatry; Fava (2006) Am J Psychiatry; McGrath (2006) Am J Psychiatry47
![Page 48: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/48.jpg)
Likelihood of discontinuing treatment increases with each new medication attempt
Systemic Drug Side Effects
Weight Gain
Constipation
Diarrhea
Nausea
Drowsiness
Insomnia
Decreased Libido
Nervous Anxiety
Increased Appetite
Decreased Appetite
Fatigue
Headache/Migraine
Abnormal Ejaculation
Impotence
Sweating
Tremor
Treatment Discontinuation Side Effects
Weakness
Dry Mouth
DizzinessTrivedi (2006) Am J Psychiatry; Rush (2006) Am J Psychiatry; Fava (2006) Am J Psychiatry; McGrath (2006) Am J Psychiatry; Neuronetics, Inc. (data on file)
![Page 49: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/49.jpg)
ECT – origins• Origin in 1700’s – Middlesex Hospital
– machine with weak electrical current used for range of illnesses.– John Birch, English neurosurgeon, used it to shock the brains of
depressed patients– Benjamin Franklin, after shocked, recommended electric shock for
tx of mental illness
• Ugo Cerletti – 1935 – noted (incorrectly) that epilepsy and schizophrenia didn’t occur in same patient
• Problems with ECT – memory loss, anesthesia risk• Cost of $6400 for eight treatments• 80% improvement • 33,000 hospitalized Americans – ECT in 1980, last year for
NIMH figures– http://www.faqs.org/health/topics/19/Electroconvulsive-therapy.html
![Page 50: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/50.jpg)
But even before Freud…
• Electromagneitc induction – 1831 (Michael Faraday & Joseph Henry)
• 1st demonstrated by Faraday August 29, 1831
![Page 51: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/51.jpg)
Faraday’s Law of Induction
TMS Magnetic
field
Induced neuronal current
![Page 52: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/52.jpg)
From electricity to magnetism
• Bartholow, R (1874)– Stimulation of human brain
(exposed cortex) of patient with cranial defect.
• d’Arsonval – “Phosphenes and vertigo” induced inside powerful magnetic coil
• Silvanus P. Thomson, Ph.D. – new type of magnetic stimulation (1910)
Thompson, SP. “A Physiological Effect of an Alternating Magnetic Field.” Proceedings of the Royal Society of London B82:396-399, 1910
![Page 53: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/53.jpg)
First patent application for magnetic therapy:
• 1902 Adrian Pollacsek and Berthold Beer – Vienna, Austria for a “therapeutical apparatus”
• Electromagnetic coil, placed over the skull was noted to “pass vibrations into the skull” and “treat depression and neuroses.”
![Page 54: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/54.jpg)
A quick look back in psychiatric history - redux
Freud: The Interpretation of Dreams – 1885 - 1890
Ugo Cerletti 1935 Prozac - 1987
ShockingShrinking Drugging
Silvanus P. Thompson, Ph.D. (1910)
Zapping
![Page 55: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/55.jpg)
First modern TMS:
• Barker AT, et al. “Non-invasive magnetic stimulation of the human motor cortex. The Lancet 1:1106-1107, 1985.
• 1st device – designed by Barker – Univ. of Sheffield, England.– 100 microsecond, 2 T
pulse
![Page 56: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/56.jpg)
Coil types and rationale
From Matt Edwardson, MD – Research Fellow and Acting Instructor, Dept. of Neurology, Univ. of WA 10/16/2011
![Page 57: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/57.jpg)
An unusual side effect of imaging (2004)…
• CONCLUSIONS: “These preliminary data suggest that the EP-MRSI scan induces electric field that are associated with reported mood improvement in subjects with bipolar disorder.”
![Page 58: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/58.jpg)
![Page 59: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/59.jpg)
Neuron
NeuroStar TMS Directly Depolarizes Cortical Neurons
Pulsed magnetic fields from NeuroStar: •induce a local electric current in the cortex which depolarizes neurons •eliciting action potentials•causing the release of chemical neurotransmitters
Neurons are “electrochemical
cells” and respond to either electrical or
chemical stimulation
![Page 60: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/60.jpg)
NeuroStar Releases Neurotransmitters in the Brain
Depolarization of neurons in the DLPFC causes local neurotransmitter release
Depolarization of pyramidal neurons in the DLPFC also
causes neurotransmitter release in deeper brain neurons
Activation of deeper brain neurons then exerts secondary effects on remaining portions of
targeted mood circuits
Dorsolateral prefrontal
cortex
Anterior cingulate
cortex
Kito (2008) J Neuropsychiatry Clin Neurosci
These effects These effects are associated are associated
with with improvements in improvements in
depressive depressive symptomssymptoms
![Page 61: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/61.jpg)
ECT vs. TMSECT TMS
Anesthesia, LOC Yes No
Induction of seizure Yes No
Systemic effects Anesthetic drugs, increase HR
none
Treatment schedule 3X/ week (8 -15 tx) Daily, M-F, six weeks (30 tx)
Rapidity of onset 2 – 3 treatments 2 – 3 weeks
Mechanism of action SEIZURE. Massive NT release; rise in sz threshold
Precise, LOCAL release of NT’s. Reactivation of neural circuits.
Side effects Memory loss, confusion Essentially none (mild HA 1st week)
Psychosocial impact can’t work Drive to and from tx’s, work improved
After-effects Mild (usually transient) memory loss
None. Pro-cognitive
Insurance coverage Almost always Rare. Improving
![Page 62: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/62.jpg)
From Michael Farraday to today
![Page 63: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/63.jpg)
![Page 64: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/64.jpg)
Does it work?• Original registration trial
– 307 major depressed patients• 67% women
• 93% recurrent depressives
• 43% had been hospitalized already
– 42 sites– Treatment per label
• Results: ½ patients responded; 1/3 of patients remitted.
• 80% patients completed the treatment.
![Page 65: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/65.jpg)
Who Was Studied?• Primary diagnosis: DSM-IV Major Depressive Disorder
– Unipolar type, non-psychotic– Moderate to severe symptoms at baseline– Approximately one-third of patients had a co-morbid anxiety
disorder (OCD excluded)
• Antidepressant Treatment History:– Average number of antidepressant medication trials in current
episode = 4 (range: 1 to 23 attempts)• Majority of treatment attempts were unable to achieve adequate
dose and duration of treatment due to intolerance
– In the indicated patient population, all patients failed to achieve satisfactory benefit from one antidepressant medication at an adequate dose and duration in current episode
Demitrack and Thase (2009) Psychopharm Bulletin
65
![Page 66: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/66.jpg)
O’Reardon, JP, et al. (2007) Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multi-Site Randomized Controlled Trial. Biol Psychiatry 62:1208-1216.
![Page 67: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/67.jpg)
Optimization of TMS (‘OPT-TMS’) Study
• NIMH-funded, independent of industry • N=190 patients, 4 premier academic sites • Primary outcome measure: % Remission - Active 15% vs Sham 4% (P =
0.015); Odds Ratio of achieving remission: 4.2 (95%CI, 1.3-13.2)
Major Findings:• MADRS total score decreased:16.6%
(Active) vs 6.9% (Sham) p=0.01 (Effect size: 0.51)
• 30% of patients achieved remission in open-label extension phase
• Excellent safety and adherence
Conclusion: “Daily left prefrontal rTMS as monotherapy produced statistically significant and clinically meaningful antidepressant therapeutic effects greater than sham.”
Mark S. George, MD; Sarah H. Lisanby, MD; David Avery, MD; William M. McDonald, MD; Valerie Durkalski, PhD; Martina Pavlicova, Phd; Berry Anderson, Phd, RN; Ziad Nahas, MD; Peter Bulow, MD; Paul Zarkowski, MD;Paul E. Holtzheimer III, MD; Theresa Schwartz, MS; Harold A. Sackeim, PHD
![Page 68: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/68.jpg)
Recent TMS Literature Review• Roughly 30 controlled clinical research studies to date• Most recent meta-analysis (Slotema, et al, 2010):
– Included analysis of 34 studies involving 1,383 patients– Estimated standardized effect size = 0.55 (P < 0.001)
Conclusion: “…rTMS deserves a place in the standard toolbox of psychiatric treatment methods, as it is effective for depression…and has a mild side effect profile….”
1.Slotema, CW, Blom, JD, Hoek, HW, Sommer, IEC. (2010) Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)J Clin Psych 71(7):873-84.
2.Schutter, DJLG. (2009) Antidepressant Efficacy of High-Frequency Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex in Double-Blind Sham-Controlled Designs: A Meta-Analysis. Psychol Medicine, 39:65-75.
![Page 69: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/69.jpg)
• No systemic side effects
• No adverse effect on cognition
• Most common adverse event associated with treatment was scalp pain or discomfort– < 5% of patients discontinued due to adverse events
• No seizures with NeuroStar device during clinical studies (over 10,000 treatments)
• Rare risk of seizure with NeuroStar TMS in post-market use (0.003% per treatment, <0.1% per acute treatment course) (>150,000 treatments in post-marketing experience to date)
• Long term safety demonstrated in 6 months follow-up
NeuroStar TMS Therapy: Safety Overview
Janicak, et al. J Clin Psychiatry, 2008; Janicak, et al. Brain Stimulation, 2010.
![Page 70: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/70.jpg)
No Evidence of Emergent Suicidal Ideation
* Shift Score indicates the percent of subjects who experienced a change in HAMD Item 3 score from 0 or 1 at baseline to 3 or 4 at later point in time.
HA
MD
Ite
m 3
Su
icid
al I
dea
tio
nS
hif
t S
core
(%
)*
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
Baseline Week 2 Week 4 Week 6
NeuroStar TMS Therapy (n=155)
Sham TMS (n=146)
Janicak (2008) J Clinical Psychiatry.
![Page 71: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/71.jpg)
Long Term Follow Up After Acute Treatment
ACUTE BENEFIT(6 Weeks)
TAPER(3 Weeks)
LONG TERM OUTCOME ASSESSMENT
(6 Months)
RCT or Open-Label Extension Study Long-Term Follow-Up Study
Transition from TMS to
pharmacotherapy
Antidepressant medication monotherapy w/TMS rescue as
add-on if needed through 6 Months
Janicak, et al. Brain Stimulation, 2010.
![Page 72: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/72.jpg)
Long Term Follow Up After Acute Treatment
Janicak, et al. Brain Stimulation, 2010.
• Safety confirmed during long term, open-label 6 month follow up period
• During open-label follow up on antidepressant medication monotherapy,– ~37% of patients required TMS reintroduction– ~85% of patients who received TMS reintroduction benefited
• Net incidence of illness relapse under these open-label follow up conditions: 11%– Six-month relapse with antidepressant treatment alone in
STAR*D study was 35-50% (Level 2 and 3 range)
![Page 73: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/73.jpg)
The story of Geraldine…
Photos used with patient’s permission
IDS-SR
CGI -S
![Page 74: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/74.jpg)
Learning points I hope we have achieved…
• Precise diagnosis.
• Improved concepts of ADHD presentation in children and adults.
• Avoid obvious drug-drug interactions.
• Avoid excess/inappropriate BZD’s.
• Avoid over-use of SGA’s.
• Understand TMS and where it fits into current psychiatric treatments
![Page 75: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/75.jpg)
Contact information:Louis B. Cady, M.D.
www.cadywellness.com
www.indianaTMS-cadywellness.com
Office: 812-429-0772E-mail: [email protected]
4727 Rosebud Lane – Suite FInterstate Office Park
Newburgh, IN 47630 (USA)
![Page 76: Scratching Your Head Psychiatry II: How to Practice INSIDE the Allopathic Box](https://reader037.fdocuments.us/reader037/viewer/2022103000/556e464dd8b42a16278b5240/html5/thumbnails/76.jpg)